On Tuesday, Shares of Becton, Dickinson and Co. (NYSE:BDX), lost -0.35% to $137.71.
BD Life Sciences declared it has accomplished the acquisition of Cellular Research, Inc.
BD is a global leader in characterizing and isolating single cells for analysis, with more than 30 years of experience in developing cell sorting technologies, known collectively as flow cytometry. This acquisition sets the stage for the next generation of commercial tools in the field of single cell genomic analysis, widely acknowledged by leading academic and industry researchers as the next frontier of biological discovery and clinical advancement. Cellular Research has developed advanced tools for massively parallel single cell genetic analysis based on their proprietary Molecular Indexing technology to enable gene expression profiles from single cells.
Combined, the BD and Cellular Research technologies provide researchers an integrated sample prep workflow to quantify and study gene expression in large numbers of individual cells, enabling higher resolution biology. The comprehensive workflow is intended to enable researchers to make new discoveries in single cell analysis, promoting the understanding of the genomic diversity of single cells and assisting to identify new approaches for targeted clinical diagnostics and therapies in important fields such as immunology, immune-oncology and personalized medicine.
Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide.
Shares of Fidelity National Information Services (NYSE:FIS), declined -0.91% to $65.37, during its last trading session.
FIS, declared the launch of India’s first financial inclusion lab in Bengaluru. The lab is aimed at developing innovative ways to extend banking access to India’s millions of underbanked citizens.
The lab is the first of its kind in India and the seventh FIS lab focused on innovation. It is designed to provide a working, collaborative environment for FIS to cooperate with business leaders, government organizations and NGOs across the country to create and test solutions that will assist enhance financial literacy for the majority of India’s unbanked population. The lab’s interactive data tools also will assist identify roadblocks to greater financial inclusion. For example, one of the lab’s first projects is the development of kiosk-based applications that can be deployed throughout the country to assist promote financial literacy with students.
“FIS is proud to foster innovation and entrepreneurship that addresses societal needs through engagement of different stakeholders,” said Raja Gopalakrishnan, FIS executive vice president, Global Financial Institutions. “FIS’ Financial Inclusion Lab will provide a platform for knowledge sharing and enabling high impact sustainability programs that can be utilized by banks and other financial institutions in the future. We are very proud that we can give back to the communities where some of our employees live and work in such a meaningful way.”
Fidelity National Information Services, Inc. provides banking and payments technology, consulting, and outsourcing solutions worldwide. Its Financial Solutions Group segment offers core processing software applications to run banking processes; retail banking delivery applications that enable financial institutions to integrate and streamline customer-facing operations and back-office processes; fraud, risk administration, and compliance solutions; syndicated loan applications that support wholesale and commercial banking operations; and onshore and offshore commercial services, such as consulting engagements, application development projects, operations support, and infrastructure administration, in addition to integrated consulting and advisory, technology, and IT transformation services.
At the end of Tuesday’s trade, Shares of DexCom, Inc. (NASDAQ:DXCM), gained 4.77% to $89.57.
Dexcom, declared that the U.S. Food and Drug Administration (FDA) has approved the Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System. With wireless Bluetooth technology built into the device transmitter, the G5 Mobile CGM System is the first and only fully mobile CGM system approved by the FDA for both adults and children as young as 2 years of age that sends glucose data directly to a smartphone, freeing users from the need to carry a separate receiver. The new transmitter securely sends vital glucose information directly to an app on iOS-enabled devices for real-time diabetes administration. Android applications will follow early next year. Like its predecessor, the G4 PLATINUM CGM with Share, users can also select up to five designated recipients, or “followers”. These followers can remotely monitor a patient’s glucose information and receive alert notifications from almost anywhere.
“Dexcom is rapidly advancing technology for continuous glucose monitoring devices to improve diabetes administration. Since January, the company has introduced the G4 PLATINUM CGM with Share, apps to enable the first CGM on the Apple Watch™ and now the Dexcom G5® Mobile CGM. These advances are making diabetes administration more convenient and flexible than ever before,” stated Kevin Sayer, President, and Chief Executive Officer of Dexcom. “We are excited for the promise this new technology holds for patients and caregivers.”
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes.
Finally, Palo Alto Networks Inc (NYSE:PANW), ended its last trade with 2.21% gain, and closed at $158.44.
Palo Alto Networks declared availability of the PA-7080, the newest and most powerful addition to its family of next-generation firewalls.
Large enterprises and telecommunications service providers are constant targets of cyberattacks. Cybercriminals seek to steal customer information from their data centers, disrupt services and leverage service provider networks as vectors for attacks on businesses and consumers. As data centers and networks grow in capacity, speed, and complexity, a security offering that delivers prevention against cyberattacks at scale is needed.
Palo Alto Networks addresses this challenge head-on with the Palo Alto Networks security platform that comprises of the Palo Alto Networks Next-Generation Firewall, Threat Intelligence Cloud, and Advanced Endpoint Protection. The platform eliminates the security, performance, and operational shortcomings of legacy products and siloed security architectures. It is designed to prevent successful cyberattacks while delivering scalable performance, policy automation, and orchestration.
Palo Alto Networks, Inc. provides enterprise security platform to enterprises, service providers, and government entities worldwide. Its platform comprises Next-Generation Firewall that delivers application, user, and content visibility and control, in addition to protection against network-based cyber threats; and Threat Intelligence Cloud that offers central intelligence capabilities, in addition to automated delivery of preventative measures against cyber attacks.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
